Is Prestige Brand Holdings Inc (PBH) overvalued? · P/E 19, rev $1.09B
Prestige Brand Holdings Inc (PBH) is a drug manufacturers - specialty & generic company listed on US.
This page asks whether Prestige Brand Holdings Inc (PBH) looks expensive on cached numbers — not a short thesis.
Latest reported PBH revenue for 2026-03-31 was $1.09B. Net income was $190.3M. Revenue was down 4.3% from 2025-03-31 to 2026-03-31. PBH currently screens at market cap $4.00B and trailing P/E 18.9.
PBH currently screens at market cap $4.00B and trailing P/E 18.9. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next PBH 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the PBH stock page for the full model, not this heading.
Not investment advice.